Close

Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, NY

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Syracuse, NY to Lotte Biologics.

The divestiture is part of Bristol Myers Squibb’s ongoing evolution of its manufacturing network to support its product portfolio. As part of the transaction, Lotte Biologics has offered all employees at the site employment within its business. Additionally, Lotte Biologics has acquired the Syracuse site’s operations and assets, which includes the property, plant and equipment.

Bristol Myers Squibb has entered into a newly established contract manufacturing organization (CMO) relationship with Lotte, under which Lotte Biologics will manufacture product for Bristol Myers Squibb at the Syracuse facility.

 

Latest stories

Related stories

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back